AEON Biopharma, Inc.

General ticker "AEON" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $11.2M (TTM average)

AEON Biopharma, Inc. does not follow the US Stock Market performance with the rate: -41.8%.

Estimated limits based on current volatility of 10.0%: low 0.27$, high 0.33$

Factors to consider:

  • Current price 51.0% below estimated low
  • Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [0.57$, 2.78$]
  • 2026-12-31 to 2027-12-31 estimated range: [0.49$, 2.27$]

Financial Metrics affecting the AEON estimates:

  • Positive: with PPE of -0.3 at the end of fiscal year the price was neutral
  • Negative: negative Operating income
  • Negative: negative Operating cash flow
  • Positive: -0.14 < Investing cash flow per share per price, % of -0.04
  • Positive: Interest expense per share per price, % of 0 <= 0
  • Negative: negative Net income

Similar symbols

Short-term AEON quotes

Long-term AEON plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $145.97MM $0.00MM
Operating Expenses $348.09MM $72.98MM $12.80MM
Operating Income $-348.09MM $72.98MM $-12.80MM
Non-Operating Income $-36.55MM $-30.98MM $-26.42MM
R&D Expense $33.05MM $14.18MM $4.09MM
Income(Loss) $-384.63MM $42.01MM $-39.22MM
Net Income(Loss)* $-384.63MM $42.01MM $-39.22MM
Stockholders Equity $-153.04MM $-28.57MM $-55.03MM
Assets $6.84MM $3.14MM $5.56MM
Operating Cash Flow $-47.83MM $-20.29MM $-17.31MM
Capital expenditure $0.00MM $0.00MM $0.00MM
Investing Cash Flow $0.00MM $0.00MM $-0.00MM
Financing Cash Flow $14.00MM $15.15MM $20.30MM
Earnings Per Share** $-744.83 $77.74 $-3.95

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.